logo

For the Inventor, By the Inventor

Ibaraki, Japan

Kazuo Matsumoto

This inventor holds 7 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1977-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Matsumoto. Retrieved from https://idiyas.com/inventor/kazuo-matsumoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Kawanishi, JA (1977)
  • Ibaraki, JP (1984 - 1994)

Company Filing History:

goldMedal7 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1977-1994

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5312826 - N,3-disubstituted alaninamide derivatives (1994-05-17),
2. 5202312 - Imidazole-containing peptides having immunomodulatory activity (1993-04-13),
3. 5051441 - Imidazoline derivative (1991-09-24),
4. 4642313 - Furyloxazolylacetic acid derivatives and processes for preparing same (1987-02-10),
5. 4535089 - Alkyloxazolylacetic acid derivative for the treatment of hyperlipidemia (1985-08-13),
6. 4460596 - Thienyloxazolylacetic acid derivatives and process for preparing (1984-07-17),
7. 4061650 - 5-Trihalogenomethyl-4,5-dihyro-oxazole-4-carboxylic acid esters (1977-12-06),

Title: Kazuo Matsumoto: Innovator in Pharmaceutical Chemistry

Introduction

Kazuo Matsumoto is a distinguished inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work focuses on developing innovative compounds with potential therapeutic applications.

Latest Patents

Matsumoto's latest patents include the development of N,3-disubstituted alaninamide derivatives. This patent discloses a dicarboxylic acid compound with various substituents that can be utilized in pharmaceutical formulations. Another notable patent involves imidazole-containing peptides that exhibit immunomodulatory activity. These peptides are designed to treat autoimmune diseases such as rheumatoid arthritis and multiple sclerosis, showcasing Matsumoto's commitment to addressing critical health challenges.

Career Highlights

Kazuo Matsumoto is currently employed at Tanabe Seiyaku Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has not only advanced scientific knowledge but also contributed to the development of new therapeutic agents.

Collaborations

Matsumoto has collaborated with notable colleagues, including Kohki Takashima and Tameo Iwasaki. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Kazuo Matsumoto's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…